Presented by Meseret Jimale, PSC Biotech Corporation This presentation will review two of the top four areas in Drugs and Devices where frequent FDA Inspection observations were cited in the past five years. For drugs, the topics of interest are investigations on unexplained discrepancies and responsibilities of Quality control unit while for devices, the focus […]